Last week I wrote that we, a firm known mostly for its focus on B2B SaaS, have invested in startups working on autonomous navigation for spacecraft, personalized cancer vaccines, and micro-drones that hunt mosquitoes (stealth), among other companies that significantly expand the scope of what software investing meant traditionally.